Legend Biotech GAAP EPS of -$0.40 misses by $0.10, revenue of $79.46M misses by $16.2M Source link
Browsing: Biotech
Newly public biotech Kyverna Therapeutics could be a blockbuster cell therapy developer for autoimmune disease, according to Morgan Stanley. Analyst…
Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S.…
Moleculin Biotech files to sell 14.09M shares for holders Source link
Biotech company Arvinas could see its shares rally from a potential medium- to long-term commercial opportunity, according to Goldman Sachs.…
Trinity Biotech partners with Bayer to launch CGM device in China and India Source link
It’s been nearly six years since biotech billionaire Dr. Patrick Soon-Shiong wrote a check for $500 million to buy the…
We’re in a golden age of medical discovery. Consider just a handful of new treatments approved in 2023: Perhaps the…
Lina Moiseienko/iStock Editorial via Getty Images The recent momentum in biotech deal-making, the rising interest in weight-loss drugs, and the…
“It’s time for the Biden administration to nix this misguided IP waiver once and for all. ” Several countries are…